ASMOSERINE INDIVIDUAL
ASMOSERINE INDIVIDUAL
Authorised
- Tetracycline hydrochloride
- Tylosin tartrate
Product identification
Medicine name:
ASMOSERINE INDIVIDUAL
Active substance:
- Tetracycline hydrochloride
- Tylosin tartrate
Target species:
-
Common canary
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Tetracycline hydrochloride3.00/milligram(s)1.00Tablet
-
Tylosin tartrate1.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Common canary
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01RA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Available only in Spanish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Latac S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Latac S.L.
Responsible authority:
- The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
- 2703 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
es-puar-asmoserine-individual-es.pdf
Spanish (PDF)
Download Published on: 9/11/2022
How useful was this page?:
